Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyperlipidemia and Mixed Dyslipidemia”

102 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 102 results

Testing effectiveness (Phase 2)Study completedNCT05256654
What this trial is testing

LY3561774 in Participants With Mixed Dyslipidemia

Who this might be right for
DyslipidemiasLipid Metabolism DisordersMetabolic Diseases+1 more
Eli Lilly and Company 205
Large-scale testing (Phase 3)Study completedNCT00289900
What this trial is testing

Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)

Who this might be right for
Mixed Hyperlipidemia
Merck Sharp & Dohme LLC 2,340
Large-scale testing (Phase 3)Study completedNCT02100514
What this trial is testing

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events

Who this might be right for
Hyperlipidemia
Pfizer 746
Not applicableEnded earlyNCT01228019
What this trial is testing

Niacin (+) Laropiprant (TREDAPTIVE) Re-examination Study (MK-0524A-119)

Who this might be right for
HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 1,166
Not applicableStudy completedNCT07119658
What this trial is testing

Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial

Who this might be right for
HypertensionHyperglycemiaDyslipidemia+5 more
Indiana University 20
Large-scale testing (Phase 3)Study completedNCT05532800
What this trial is testing

The Efficacy and Safety of JS002 PFS and AI in Patients With Primary Hypercholesterolemia and Mixed Hyperlipidemia

Who this might be right for
Hyperlipemia
Shanghai Junshi Bioscience Co., Ltd. 255
Large-scale testing (Phase 3)Study completedNCT02739984
What this trial is testing

Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia

Who this might be right for
HypercholesterolemiaMixed DyslipidemiaType 2 Diabetes
Amgen 424
Testing effectiveness (Phase 2)Study completedNCT04516291
What this trial is testing

A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)

Who this might be right for
DyslipidemiasHyperlipidemiasHyperlipoproteinemias
Pfizer 286
Early research (Phase 1)Study completedNCT06923956
What this trial is testing

Single Dose Oral Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated Tablets in Healthy Adult Human Subjects Under Fasting Conditions.

Who this might be right for
HypercholesterolaemiaMixed DyslipidaemiaCardiovascular Diseases
Humanis Saglık Anonim Sirketi 14
Large-scale testing (Phase 3)Study completedNCT00139061
What this trial is testing

Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate

Who this might be right for
Hyperlipidemia
Pfizer 128
Post-approval studies (Phase 4)Study completedNCT00552747
What this trial is testing

Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease

Who this might be right for
Coronary Heart DiseaseHyperlipidemia
National Heart Institute, Mexico 76
Large-scale testing (Phase 3)Study completedNCT01968967
What this trial is testing

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events

Who this might be right for
Hyperlipidemia
Pfizer 2,139
Large-scale testing (Phase 3)Ended earlyNCT01335997
What this trial is testing

Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143)

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 1,139
Not applicableStudy completedNCT00309712
What this trial is testing

Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study

Who this might be right for
Type II Diabetes MellitusMixed Dyslipidemia
Intermountain Health Care, Inc. 300
Large-scale testing (Phase 3)Active Not RecruitingNCT07473960
What this trial is testing

IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

Who this might be right for
Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
Innovent Biologics (Suzhou) Co. Ltd. 198
Large-scale testing (Phase 3)Study completedNCT00362934
What this trial is testing

Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin

Who this might be right for
Hyperlipidemia
Solvay Pharmaceuticals 516
Large-scale testing (Phase 3)Study completedNCT02458287
What this trial is testing

Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia

Who this might be right for
Hyperlipidemia
Pfizer 299
Large-scale testing (Phase 3)Study completedNCT00136799
What this trial is testing

Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia

Who this might be right for
Mixed DyslipidemiaHypercholesterolemia
Novartis 325
Large-scale testing (Phase 3)WithdrawnNCT02670434
What this trial is testing

Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia

Who this might be right for
HyperlipidemiaDyslipidemia
Kowa Research Institute, Inc.
Testing effectiveness (Phase 2)Study completedNCT00941603
What this trial is testing

Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)

Who this might be right for
Primary HypercholesterolemiaMixed Hyperlipidemia
Merck Sharp & Dohme LLC 619
Next Page